DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20185219

The world of synbiotics: a review of literature and clinical evidence in diarrhoea from the lens of a paediatrician

Pramod Jog

Abstract


The use of synbiotics in the management of acute diarrhoea in children is becoming a common practice in India. However, since this is an upcoming modality of treatment, it is essential to review the scientific rationale and evidence on clinical efficacy and safety in the context of paediatric diarrhoea. In addition, most synbiotics contain a combination of multiple probiotics along with a prebiotic. Thus arises, a parallel need to understand whether a combination of probiotics performs better than single probiotics, hence justifying the rationale for such combinations. A review of available evidence suggests that synbiotics are indeed safe and superior in efficacy to single probiotics (like Bacillus clausii, Lactobacillus rhamnosus GG etc) and that there is a good body of evidence to support the efficacy and tolerability of synbiotics in the management of paediatric acute gastroenteritis. There is also evidence to suggest that combination probiotics have superior benefits compared to single probiotics, thus justifying their use as part of synbiotics. The overall benefits of synbiotics reported in various clinical trials on paediatric diarrhoea include, a rapid normalization of the gastrointestinal flora, a reduction in the duration of diarrhoea, quicker improvement in stool consistency, lesser administration of additional medications like antibiotics, antiemetics and antipyretics, higher physician reported treatment satisfaction scores and enhanced overall efficacy against gastrointestinal pathogens, including diarrhoea of rota virus origin. Hence, synbiotics put up a strong case to look beyond probiotics and single probiotic formulations in paediatric diarrhoea.


Keywords


Combination probiotics, Diarrhoea, Multi-strain probiotics, Prebiotics, Probiotics, Synbiotics

Full Text:

PDF

References


Markowiak P., Katarzyna S. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(1021):2-30

Vandenplas Y, De Hert SG. Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children. Aliment Pharmacol Ther. 2011;34(8):862-7

Timmerman HM, Koning CJ, Mulder L, Rombouts FM, Beynen AC. Monostrain, multistrain and multispecies probiotics—a comparison of functionality and efficacy. Int J Food Microbiol. 2004;96(3):219-33.

Dewi MR, Soenarto Y, Karyana IP. Efficacy of synbiotic treatment in children with acute rotavirus diarrhea. Paediatrica Indon. 2015;55(2):74-8.

Narayanappa D. Randomized double blinded controlled trial to evaluate the efficacy and safety of Bifilac in patients with acute viral diarrhea. Indian J Pediat. 2008 ;75(7):709-13.

Islek A, Sayar E, Yilmaz A, Baysan BO, Mutlu D, Artan R. The role of Bifidobacterium lactis B94 plus inulin in the treatment of acute infectious diarrhea in children. Turk J Gastroenterol. 2014;25(6):628-33.

Collado MC, Jalonen L, Meriluoto J, Salminen S. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus. Asia Pac J Clin Nutr. 2006;15(4):570-5

Chapman CM, Gibson GR, Rowland I. In vitro evaluation of single-and multi-strain probiotics: Inter-species inhibition between probiotic strains, and inhibition of pathogens. Anaerobe. 2012;18(4):405-13.

MacPherson CW, Shastri P, Mathieu O, Tompkins TA, Burguière P. Genome-wide immune modulation of TLR3-mediated inflammation in intestinal epithelial cells differs between single and multi-strain probiotic combination. PloS one. 2017;12(1):e0169847.

Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, De Vincenzo A, et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMC Infect Dis. 2010;335(7615):340.

Bhatnagar S, Lodha R, Choudhury P, Sachdev HP, Shah N, Narayan S et al. IAP Guidelines 2006 on Management of Acute Diarrhea. Indian Pediat. 2007;44:380-389

Guarino A, Ashkenazi S, Gendrel D, Vecchio AL, Shamir R, Szajewska H. et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe: Update 2014. JPGN 2014;59(1):132-52

Ramchandra Bastola, Bhawana Bastola et al. A Randomized Open Label Comparative Clinical Study of a Probiotic against a Symbiotic in the Treatment of Acute Diarrhoea in Children. Int J Med Res Health Sci. 2017;6(9):96-100

Grossi E, Buresta R, Abbiati R, Cerutti R, Pro-DIA study group. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with acute diarrhea: a multicenter, randomized study in primary care. Journal of Clinical Gastroenterol. 2010;44:S35-41.

Passariello A, Terrin G, Cecere G, Micillo M, De Marco G, Di Costanzo M, et al. Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea. Aliment Pharmacol Ther. 2012;35(7):782-8.

Yazar AS, Güven Ş, Dinleyici EÇ. Effects of zinc or synbiotic on the duration of diarrhea in children with acute infectious diarrhea. Turk J Gastroenterol. 2016;27(6):537-40.

Van den Nieuwboer M, Brummer RJ, Guarner F, Morelli L, Cabana M, Claassen E. et al. Safety of probiotics and synbiotics in children under 18 years of age. Benef Microbes. 2015;6(5):615-30.

Dinleyici EC, Dalgic N, Guven S, Ozen M, Kara A, Arica V, et al. The effect of a multispecies synbiotic mixture on the duration of diarrhea and length of hospital stay in children with acute diarrhea in Turkey: Single blinded randomized study. Eur J Pediatr 2013;172(4):459-64.

Ahmed RR, Ghafoor MA, Kazi Y, Bai C, Khan N. Role of Synbiotic (Combination of Pre and Probiotic) in the Management and Prevention of Acute Watery Diarrhoea. World App Sci J 2014;32(2):226-30.

García-Menor E, García-Marín F, Vecino-López R, Horcajo-Martínez G, de Ibarrondo Guerrica-Echevarría MJ et al. A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Additional Benefit of a Multistrain Synbiotic (Prodefen®) in the Clinical Management of Acute Viral Diarrhea in Children. Global Pediatric Health 2016;3:1-8

Expedito T. Yala. The clinical efficacy of multi- strain probiotics (protexin) in the management of acute gastroenteritis in children two months to two years old. 2010;11(2):86-91

Gundogdu Z. Effect of a synbiotic on infantile acute gastroenteritis. Benef Microbes. 2013; 4(3):231-5.